Send us a Protocol

Resources

WWCT
Iqvia
Caidya
Emmes
Klifo
Catalyst
Advanced Clinical
Roche
Alimentiv

TRI Resources

Enhance your RBQM knowledge with TRI’s expert-led resources.

Select a resource type

Select a topic

Rachel Penn Auto You said: Alt text fopr this image please Copilot said: Alt text: Healthcare technology graphic showing the message “Why On-Site Monitoring Misses Trial Risks” alongside a globe with medical and clinical research icons, and a professional using a tablet against a blue digital healthcare background.

Why On-Site Monitoring Misses Trial Risks

Why on-site monitoring alone can miss emerging trial risks and why risk-based monitoring delivers earlier, smarter oversight.
Read More
Cover image for “The Complete Guide to RBQM Software in 2026” featuring a blue healthcare technology interface with a tablet displaying analytics charts, digital medical and data visualization icons, and a futuristic health-tech dashboard. TRI logo shown in the bottom-left corner.

The Complete Guide to RBQM Software in 2026

A practical guide to choosing and implementing RBQM software that strengthens centralized monitoring, patient safety, and clinical trial oversight.
Read More
Person completing an inspection checklist on a clipboard, representing the evaluation of oversight software for regulatory inspections.

How to assess oversight software for inspections

A practical guide to assessing oversight software for inspections, with the records, and compliance evidence regulators expect to see.
Read More
August 2026 RBQM newsletter cover highlighting summer insights, AI in RBQM, monitoring systems, and the CRA gap.

The Quality Issue August 2026

As summer ends and conference season begins, we explore AI's growing role in RBQM, smarter monitoring strategies, and how to close the evolving CRA gap.
Read More
Professional working at multiple data-monitoring screens beside the title “Choosing a Centralized Monitoring Platform” and the TRI logo.

Choosing a Centralized Monitoring Platform

Six key questions to help you choose a centralized monitoring platform that supports effective RBQM and inspection-ready oversight
Read More
Laptop displaying analytics charts beside the headline, “Why low-volume Studies Need a Different Approach,” with TRI branding.

Why Low-Volume Studies Need a Different Approach

Low-volume studies demand subject-level oversight, where patient context and emerging risks matter more than population-wide trends.
Read More
Person receiving a vaccination or injection with healthcare-themed digital graphics and the headline, “When One Subject is the Signal,” alongside TRI branding.

Rethinking Safety Oversight in Small Trials

In small trials, the biggest safety signal may come from a single patient, if your oversight process is designed to see it.
Read More
July 2026 RBQM newsletter cover featuring a summer check-in, ACRO's RBQM Summary Report, and smarter subject monitoring.

The Quality Issue July 2026

Discover why subject monitoring is emerging as the next compliance frontier and how RBQM teams can move beyond spreadsheets.
Read More

Subscribe to get the latest RBQM insights sent straight to your inbox.